It’s the deepest look yet that investors and competitors have had at the profits and losses of the company, which has grown far beyond its rocket-ship roots to include AI, an internet service provider ...

Senate Democrats finally crack GOP unity on Trump's Iran war as Murkowski flips He set fire to his ex and her baby. Now Oklahoma is executing him. Entire human populations vanished 3,000 years ago.

The 1990s were unfortunately something of a golden era for high-profile transfers that Everton didn’t get over the line with Stan Collymore and Mark Schwarzer adding their names to the list of ...

Countries attending a first-of-its-kind summit have walked away with plans to develop national roadmaps away from fossil fuels, along with new tools to address harmful subsidies and carbon-intensive ...

ON CAMPUS. THE U.S. ATTORNEY’S OFFICE SAYS TWO MEXICAN NATIONALS ARE FACING FEDERAL CHARGES FOR ATTEMPTING TO TRAFFIC A MACHINE GUN, RIFLES AND GRENADE INTO MEXICO. ACCORDING TO A CRIMINAL COMPLAINT, ...

From immune system shifts to organ-on-a-chip experiments, Artemis 2 is as much a human health mission as it is a test flight around the moon. When you purchase through links on our site, we may earn ...

The world’s first full-dive VRMMO, Sword Art Online—known as SAO. What was meant to be a dream come true has instead transformed into a deadly game where dying in the virtual world means dying in ...

Kurt Olsen became a key player in some of President Donald Trump’s most far-fetched 2020 election reversal schemes because he believed “that something was not right” in how he saw election officials ...

A magazine’s glossy photo shoot with young Wall Streeters, including a pair from Goldman Sachs Group Inc. who opined on their spending and dating, is setting off finger-pointing inside the famously ...

U.S. figure skaters Mark Zheltyshev and Jane Calhoun qualified for the junior world championships in Estonia. However, Zheltyshev's Russian citizenship prevented the pair from entering the country.

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. A spinout planned since that deal’s October announcement ...